Pharma Markets

Global Parkinson’s Disease Market and Competitive Landscape

By Fore Pharma | Published Date: June 7, 2020 | On-Demand Data

The latest research from Fore Pharma, Global Parkinson’s Disease Market and Competitive Landscape – 2020, provides comprehensive insights into Parkinson’s Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Parkinson’s Disease market size and drug sales. It also provides insights into Parkinson’s Disease epidemiology and late stage pipeline.

This research covers the following – Parkinson’s Disease treatment options, Parkinson’s Disease late stage clinical trials pipeline, Parkinson’s Disease prevalence by countries, Parkinson’s Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:

– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Parkinson’s Disease pipeline: Find out drugs in clinical trials for Parkinson’s Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Parkinson’s Disease epidemiology: Find out number of patients diagnosed (prevalence) with Parkinson’s Disease by countries
– Parkinson’s Disease drugs: Identify key drugs marketed and prescribed for Parkinson’s Disease by countries, including trade name, molecule name, and company
– Parkinson’s Disease drugs sales: Find out the sales value for Parkinson’s Disease drugs by countries
– Parkinson’s Disease market valuations: Find out the market size for Parkinson’s Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Parkinson’s Disease drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Parkinson’s Disease drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Parkinson’s Disease market
– Develop in-depth knowledge of competition and markets
– Analyze Parkinson’s Disease drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Parkinson’s Disease market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Parkinson’s Disease Treatment Options
2. Parkinson’s Disease Pipeline Insights
2.1. Parkinson’s Disease Phase 3 Clinical Trials
2.2. Parkinson’s Disease Phase 2 Clinical Trials
2.3. Parkinson’s Disease Phase 1 Clinical Trials
3. Parkinson’s Disease Epidemiology Analysis by Countries
4. US Parkinson’s Disease Market Insights
4.1. Marketed Drugs for Parkinson’s Disease in US
4.2. US Parkinson’s Disease Market Size & Forecast
4.3. US Parkinson’s Disease Drugs Sales & Forecast
4.4. US Parkinson’s Disease Market Share Analysis
5. Germany Parkinson’s Disease Market Insights
5.1. Marketed Drugs for Parkinson’s Disease in Germany
5.2. Germany Parkinson’s Disease Market Size & Forecast
5.3. Germany Parkinson’s Disease Drugs Sales Forecast
5.4. Germany Parkinson’s Disease Market Share Analysis
6. France Parkinson’s Disease Market Insights
6.1. Marketed Drugs for Parkinson’s Disease in France
6.2. France Parkinson’s Disease Market Size & Forecast
6.3. France Parkinson’s Disease Product Sales Forecast
6.4. France Parkinson’s Disease Market Share Analysis
7. Italy Parkinson’s Disease Market Insights
7.1. Marketed Drugs for Parkinson’s Disease in Italy
7.2. Italy Parkinson’s Disease Market Size & Forecast
7.3. Italy Parkinson’s Disease Product Sales Forecast
7.4. Italy Parkinson’s Disease Market Share Analysis
8. Spain Parkinson’s Disease Market Insights
8.1. Marketed Drugs for Parkinson’s Disease in Spain
8.2. Spain Parkinson’s Disease Market Size & Forecast
8.3. Spain Parkinson’s Disease Product Sales Forecast
8.4. Spain Parkinson’s Disease Market Share Analysis
9. UK Parkinson’s Disease Market Insights
9.1. Marketed Drugs for Parkinson’s Disease in UK
9.2. UK Parkinson’s Disease Market Size & Forecast
9.3. UK Parkinson’s Disease Product Sales Forecast
9.4. UK Parkinson’s Disease Market Share Analysis
10. Europe Parkinson’s Disease Market Insights
10.1. Europe Parkinson’s Disease Market Size & Forecast
10.2. Europe Parkinson’s Disease Product Sales Forecast
10.3. Europe Parkinson’s Disease Market Share Analysis
11. Japan Parkinson’s Disease Market Insights
11.1. Marketed Drugs for Parkinson’s Disease in Japan
11.2. Japan Parkinson’s Disease Market Size & Forecast
11.3. Japan Parkinson’s Disease Product Sales Forecast
11.4. Japan Parkinson’s Disease Market Share Analysis
12. Global Parkinson’s Disease Market Insights
12.1. Global Parkinson’s Disease Market Size & Forecast
12.2. Global Parkinson’s Disease Product Sales Forecast
12.3. Global Parkinson’s Disease Market Share Analysis
13. Research Methodology

List of Tables


1: Parkinson’s Disease Phase 3 Clinical Trials, Global, 2020
2: Parkinson’s Disease Phase 2 Clinical Trials, Global, 2020
3: Parkinson’s Disease Phase 1 Clinical Trials, Global, 2020
4: Parkinson’s Disease Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Parkinson’s Disease in US, 2019
6: US Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
7: US Parkinson’s Disease Product Sales ($mn), 2016 – 2025
8: US Parkinson’s Disease Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Parkinson’s Disease in Germany, 2019
10: Germany Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
11: Germany Parkinson’s Disease Product Sales ($mn), 2016 – 2025
12: Germany Parkinson’s Disease Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Parkinson’s Disease in France, 2019
14: France Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
15: France Parkinson’s Disease Product Sales ($mn), 2016 – 2025
16: France Parkinson’s Disease Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Parkinson’s Disease in Italy, 2019
18: Italy Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
19: Italy Parkinson’s Disease Product Sales ($mn), 2016 – 2025
20: Italy Parkinson’s Disease Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Parkinson’s Disease in Spain, 2019
22: Spain Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
23: Spain Parkinson’s Disease Product Sales ($mn), 2016 – 2025
24: Spain Parkinson’s Disease Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Parkinson’s Disease in UK, 2019
26: UK Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
27: UK Parkinson’s Disease Product Sales ($mn), 2016 – 2025
28: UK Parkinson’s Disease Market Events and Trends, 2016 – 2025
29: Europe Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
30: Europe Parkinson’s Disease Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Parkinson’s Disease in Japan, 2019
32: Japan Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
33: Japan Parkinson’s Disease Product Sales ($mn), 2016 – 2025
34: Japan Parkinson’s Disease Market Events and Trends, 2016 – 2025
35: Global Parkinson’s Disease Market Size & Forecast ($mn), 2016 – 2025
36: Global Parkinson’s Disease Product Sales ($mn), 2016 – 2025

List of Figures


1: Parkinson’s Disease Pipeline by Phase (%), Global, 2020
2: Parkinson’s Disease Prevalence by Countries, 2016 – 2025
3: US Parkinson’s Disease Market Size ($mn), 2016 – 2025
4: US Parkinson’s Disease Product Sales ($mn), 2016 – 2025
5: US Parkinson’s Disease Market Share by Drugs (%), 2019
6: US Parkinson’s Disease Market – Future Market Share (%), 2025
7: Germany Parkinson’s Disease Market Size ($mn), 2016 – 2025
8: Germany Parkinson’s Disease Product Sales ($mn), 2016 – 2025
9: Germany Parkinson’s Disease Market Share by Drugs (%), 2019
10: Germany Parkinson’s Disease Market – Future Market Share (%), 2025
11: France Parkinson’s Disease Market Size ($mn), 2016 – 2025
12: France Parkinson’s Disease Product Sales ($mn), 2016 – 2025
13: France Parkinson’s Disease Market Share by Drugs (%), 2019
14: France Parkinson’s Disease Market – Future Market Share (%), 2025
15: Italy Parkinson’s Disease Market Size ($mn), 2016 – 2025
16: Italy Parkinson’s Disease Product Sales ($mn), 2016 – 2025
17: Italy Parkinson’s Disease Market Share by Drugs (%), 2019
18: Italy Parkinson’s Disease Market – Future Market Share (%), 2025
19: Spain Parkinson’s Disease Market Size ($mn), 2016 – 2025
20: Spain Parkinson’s Disease Product Sales ($mn), 2016 – 2025
21: Spain Parkinson’s Disease Market Share by Drugs (%), 2019
22: Spain Parkinson’s Disease Market – Future Market Share (%), 2025
23: UK Parkinson’s Disease Market Size ($mn), 2016 – 2025
24: UK Parkinson’s Disease Product Sales ($mn), 2016 – 2025
25: UK Parkinson’s Disease Market Share by Drugs (%), 2019
26: UK Parkinson’s Disease Market – Future Market Share (%), 2025
27: Europe Parkinson’s Disease Market Size ($mn), 2016 – 2025
28: Europe Parkinson’s Disease Product Sales ($mn), 2016 – 2025
29: Europe Parkinson’s Disease Market Share by Drugs (%), 2019
30: Europe Parkinson’s Disease Market – Future Market Share (%), 2025
31: Japan Parkinson’s Disease Market Size ($mn), 2016 – 2025
32: Japan Parkinson’s Disease Product Sales ($mn), 2016 – 2025
33: Japan Parkinson’s Disease Market Share by Drugs (%), 2019
34: Japan Parkinson’s Disease Market – Future Market Share (%), 2025
35: Global Parkinson’s Disease Market Size ($mn), 2016 – 2025
36: Global Parkinson’s Disease Product Sales ($mn), 2016 – 2025
37: Global Parkinson’s Disease Market Share by Drugs (%), 2019
38: Global Parkinson’s Disease Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies